Table 4 Postoperative changes of best-corrected visual acuity and central macular thickness from baseline evaluation
From: Efficacy and safety of primary posterior capsulotomy during phaco-vitrectomy for epiretinal membrane
Capsulotomy (−) group (n = 152) | Capsulotomy (+) group (n = 76) | P value* | |
|---|---|---|---|
BCVA change from baseline | |||
1 month, mean ± SD | − 0.127 ± 0.236 (n = 152) | − 0.089 ± 0.245 (n = 76) | 0.266 |
3 months, mean ± SD | − 0.193 ± 0.209 (n = 125) | −0.186 ± 0.285 (n = 49) | 0.841 |
6 months, mean ± SD | −0.199 ± 0.199 (n = 126) | −0.183 ± 0.229 (n = 43) | 0.661 |
12 months, mean ± SD | − 0.229 ± 0.190 (n = 137) | −0.245 ± 0.211 (n = 63) | 0.588 |
CMT change from Baseline | |||
1 month, mean ± SD | − 33.95 ± 91.74 (n = 151) | −22.54 ± 85.66 (n = 76) | 0.367 |
3 months, mean ± SD | −57.50 ± 91.63 (n = 126) | −57.22 ± 104.12 (n = 49) | 0.986 |
6 months, mean ± SD | −71.11 ± 93.75 (n = 125) | −70.23 ± 113.24 (n = 43) | 0.960 |
12 months, mean ± SD | −85.42 ± 109.01 (n = 138) | −96.08 ± 101.48 (n = 63) | 0.512 |